Multi-Industry Comments on the Voluntary Disclosure of Sesame as an Allergen
ASTA signed onto industry coalition comments to the Food and Drug Administration (FDA) in February 2021 regarding the FDA's draft guidance titled Voluntary Disclosure of Sesame as an Allergen.
02/25/2021 at 5:15 am
1
Related Resources
NCFIA Comments Regarding FDA/CBP Coordination on Prior Notice Requirements
NCFIA issued comments to the Food and Drug Administration in May 2004 regarding joint FDA and Customs and Border Protection plans for increasing integration and assessing the coordination of prior notice timeframes.
Multi-Industry Comments on FDA's Tool for the Prioritization of Food Chemicals for Post-Market Assessment
In August 2025, ASTA signed onto comments written by the Food & Beverage Issue Alliance (FBIA) encouraging FDA to leverage a science-driven, iterative approach for the prioritization of chemicals for post-market assessments. The comments call for FDA to place greater weight on public health risk-related factors, differentiate prioritization and assessment frameworks between intentionally added substances and contaminants, and to enhance transparency and stakeholder engagement opportunities.
